share_log

Nektar Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-TCG Crossover GP II, LLC(9.9%),TCG Crossover Fund II, L.P.(9.9%), etc.

SEC announcement ·  Mar 15 16:27
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more